Trulieve Cannabis Subordinate Voting Shares Financial Statements
NYSE: TRLVHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Trulieve Cannabis Subordinate Voting Shares revenue and earnings
In fiscal 2025, Trulieve Cannabis Subordinate Voting Shares generated $1.18 billion in revenue, down 0.4% from fiscal 2024, its first annual decline since 2023. Trulieve Cannabis Subordinate Voting Shares reported a net loss of $122.2 million, compared with a loss of $160.6 million a year earlier. Gross margin was 60.2% (down from 60.3%) and operating margin 12.1%.
Diluted earnings per share came in at -$0.58. Over the last 5 fiscal years, TRLV's revenue has grown at a 17.8% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Trulieve Cannabis Subordinate Voting Shares income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.19B | 1.13B | 1.22B | 931.93M | 521.53M | 252.82M |
| Revenue growth (YoY) | -0.45% | +5.07% | -7.31% | +30.72% | +78.69% | +106.29% | — |
| Cost of Revenue | 470.01M | 470.75M | 540.57M | 529.10M | 365.36M | 135.12M | 60.98M |
| Gross Profit | 711.17M | 715.75M | 588.63M | 689.13M | 566.57M | 386.42M | 191.84M |
| Operating Expenses | 567.67M | 617.97M | 810.24M | 638.96M | 362.52M | 168.11M | 78.57M |
| Selling, General & Admin | 445.21M | 510.45M | 386.16M | 447.03M | 311.36M | 155.45M | 73.42M |
| Operating Income | 143.50M | 97.78M | -221.61M | 50.16M | 204.05M | 218.30M | 113.27M |
| Interest Expense | 63.45M | 62.19M | 81.57M | 73.42M | 29.12M | 20.24M | 9.05M |
| Other Income (Expense) | -52.02M | -55.07M | -62.92M | -69.40M | -27.80M | -60.85M | -9.59M |
| Pretax Income | 91.47M | 42.71M | -284.54M | -19.24M | 176.25M | 157.45M | 103.68M |
| Income Tax | 208.11M | 197.59M | 151.36M | 163.38M | 145.72M | 94.45M | 50.59M |
| Net Income | -122.25M | -160.58M | -533.14M | -252.73M | 17.45M | 63.00M | 53.09M |
| Net Income growth (YoY) | — | — | — | -1548.71% | -72.31% | +18.65% | — |
| EPS (Basic) | -0.58 | -0.79 | -2.28 | -0.95 | 0.22 | 0.55 | 0.48 |
| EPS (Diluted) | -0.58 | -0.79 | -2.28 | -0.95 | 0.21 | 0.53 | 0.46 |
| Shares Outstanding (Basic) | 191.32M | 189.99M | 188.97M | 188.00M | 139.37M | 113.57M | 110.21M |
| Shares Outstanding (Diluted) | 191.32M | 189.99M | 188.97M | 188.00M | 146.76M | 118.33M | 115.32M |
| EBITDA | 261.13M | 210.59M | -111.79M | 166.55M | 249.84M | 230.90M | 118.35M |
| Gross Margin | 60.21% | 60.32% | 52.13% | 56.57% | 60.80% | 74.09% | 75.88% |
| Operating Margin | 12.15% | 8.24% | -19.63% | 4.12% | 21.90% | 41.86% | 44.80% |
| Net Margin | -10.35% | -13.53% | -47.21% | -20.75% | 1.87% | 12.08% | 21.00% |
This table shows 7 annual periods of Trulieve Cannabis Subordinate Voting Shares's income statement, from FY 2025 back to FY 2019, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow TRLV's reporting calendar. What is a income statement?